Tau protein kinases: Involvement in Alzheimer's disease

Cited by (646)

Items 201–300 of 646

1. Perindopril ameliorates experimental Alzheimer’s disease progression: role of amyloid β degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling
   Basim Anwar Shehata Messiha, Mohammed R.A. Ali, Mahmoud Mohamed Khattab, Amira M. Abo‐Youssef · 2020 · Inflammopharmacology
2. Role of the endolysosomal pathway and exosome release in tau propagation
   Yan, Minli, Zheng, Tingting · 2021 · Neurochemistry International
3. Genome-wide association study and functional validation implicates JADE1 in tauopathy
   Kurt W. Farrell, SoongHo Kim, Natalia Han, Megan A. Iida, Elias M. Gonzalez, Marcos Otero‐García, Jamie M. Walker, Timothy E. Richardson, Alan Edward Renton, Shea J. Andrews et al. · 2021 · Acta Neuropathologica
4. Unveiling the therapeutic potential of natural products in Alzheimer’s disease: insights from in vitro, in vivo, and clinical studies
   Nahida Aktary, Yerim Jeong, Seungji Oh, Yeju Shin, Yoonsoo Sung, Muntajin Rahman, Lívia Ramos Santiago, Jinwon Choi, Han Gyeul Song, Fahrul Nurkolis et al. · 2025 · Frontiers in Pharmacology
5. 2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors
   Kenji Fukunaga, Fumiaki Uehara, Keiichi Aritomo, Aya Shoda, Shinsuke Hiki, Masahiro Okuyama, Yoshihiro Usui, Kazutoshi Watanabe, Koichi Yamakoshi, Toshiyuki Kohara et al. · 2013 · Bioorganic & Medicinal Chemistry Letters
6. Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases
   Andrea I. Krahn, Carrow I. Wells, David H. Drewry, Lenore K. Beitel, Thomas M. Durcan, Alison D. Axtman · 2020 · ACS Chemical Neuroscience
7. TBK1 interacts with tau and enhances neurodegeneration in tauopathy
   Measho H. Abreha, Shamsideen A. Ojelade, Eric B. Dammer, Zachary T. McEachin, Duc Minh Duong, Marla Gearing, Gary Jonathan Bassell, James J. Lah, Allan I. Levey, Joshua M Shulman et al. · 2021 · Journal of Biological Chemistry
8. Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent
   Miranda E. Orr, Valentina Rose Garbarino, Angelica Salinas, Rochelle Buffenstein · 2014 · Neurobiology of Aging
9. Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer’s Disease: Analytical and Diagnostic Characterization
   Piotr Lewczuk, Natalia Lelental, Ingolf Lachmann, Max Holzer, Katharina Flach, Sebastian Brandner, Sebastiaan Engelborghs, Charlotte Elisabeth Teunissen, Henrik Zetterberg, José Luís Molinuevo et al. · 2016 · Journal of Alzheimer s Disease
10. Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements
    Divya Shastri, Vinit Raj, Sang-Kil Lee · 2024 · Ageing Research Reviews
11. The Streptomyces metabolite anhydroexfoliamycin ameliorates hallmarks of Alzheimer’s disease in vitro and in vivo
    Marta Leirós, Eva Alonso, Mostafa Ezzat Rateb, Rainer Ebel, Marcel Jaspars, Amparo Alfonso, Luis Miguel Botana · 2015 · Neuroscience
12. The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications
    Scott H. Snyder, Patricia A. Vignaux, Mustafa Kemal Ozalp, Jacob Gerlach, Ana C. Puhl, Thomas R. Lane, John Corbett, Fabio Urbina, Sean Ekins · 2024 · Communications Chemistry
13. Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
    Eun Hee Ahn, Jae‐Bong Park · 2025 · Cells
14. First Selective Dual Inhibitors of Tau Phosphorylation and Beta-Amyloid Aggregation, Two Major Pathogenic Mechanisms in Alzheimer’s Disease
    Marica Mariano, Christian Schmitt, Parisa Miralinaghi, Marco Catto, Rolf W. Hartmann, Angelo Carotti, Matthias Engel · 2014 · ACS Chemical Neuroscience
15. Knockdown of microRNA-195 contributes to protein phosphatase-2A inactivation in rats with chronic brain hypoperfusion
    Chengdi Liu, Qin Wang, De‐Kang Zong, Shuang‐Chao Pei, Yan Yan, Meiling Yan, Linlin Sun, Yang-Yang Hao, Meng Mao, Wenjing Xing et al. · 2016 · Neurobiology of Aging
16. Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review
    Xiaoman Yang, Zhuoran Ma, Piaopiao Lian, Yan Chun Xu, Xuebing Cao · 2023 · Frontiers in Molecular Neuroscience
17. Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer’s disease
    Kenji Fukunaga, Daiki Sakai, Kazutoshi Watanabe, Kazuki Nakayama, Toshiyuki Kohara, Hiroshi Tanaka, Shinji Sunada, Mika Nabeno, Masako Okamoto, Ken-Ichi Saito et al. · 2015 · Bioorganic & Medicinal Chemistry Letters
18. Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assays
    Chih‐Hsin Lin, Yu-Shao Hsieh, Yih‐Ru Wu, Chia-Jen Hsu, Hsuan-Chiang Chen, Wun‐Han Huang, Kuo‐Hsuan Chang, Hsiu Mei Hsieh‐Li, Ming‐Tsan Su, Ying‐Chieh Sun et al. · 2016 · European Journal of Pharmaceutical Sciences
19. Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-β-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells
    Lobine, Devina, Sadeer, Nabeelah, Jugreet, Sharmeen, Suroowan, Shanoo, Keenoo, Bibi Sumera, Imran, Muhammad, Venugopala, Katharigatta N., Ibrahim, Faten Mohamed, Zengin, Gokhan, Mahomoodally, Mohamad Fawzi · 2021 · Current Neuropharmacology
20. Synthesis of pyrimidin-4-one-1,2,3-triazole conjugates as glycogen synthase kinase-3β inhibitors with anti-depressant activity
    Imran Khan, Mushtaq A. Tantray, Hinna Hamid, Mohammad Sarwar Alam, Abul Kalam, Firasat Hussain, Abhijeet Dhulap · 2016 · Bioorganic Chemistry
21. Administration of Momordica charantia Enhances the Neuroprotection and Reduces the Side Effects of LiCl in the Treatment of Alzheimer’s Disease
    Hei-Jen Huang, Shu-Ling Chen, Yen-Ting Chang, Jong‐Ho Chyuan, Hsiu Mei Hsieh‐Li · 2018 · Nutrients
22. G protein‐coupled receptor kinases are associated with Alzheimer's disease pathology
    Thais Rafael Guimarães, Eric Swanson, Julia Kofler, Amantha Thathiah · 2021 · Neuropathology and Applied Neurobiology
23. Disruption of tubulin-alpha4a polyglutamylation prevents aggregation of hyper-phosphorylated tau and microglia activation in mice
    Torben Johann Hausrat, Philipp Christoph Janiesch, Petra Breiden, David Lutz, Sabine Hoffmeister‐Ullerich, Irm Hermans‐Borgmeyer, Antonio Virgilio Failla, Matthias Kneussel · 2022 · Nature Communications
24. DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's Disease
    Márcia María de Souza, Arthur Ribeiro Cenci, Kerolain Faoro Teixeira, Valkiria Machado, Majory C.G.M. Schülerb, Ana Elisa Gonçalves, Ana Paula Dalmagro, Camila André Cazarin, Leonardo L. G. Ferreira, Aldo Sena de Oliveira et al. · 2022 · Current Medicinal Chemistry
25. Role of astrocytes in sleep deprivation: accomplices, resisters, or bystanders?
    Mengxin Que, Yujuan Li, Xuan Wang, Gaofeng Zhan, Xiaoxiao Luo, Zhiqiang Zhou · 2023 · Frontiers in Cellular Neuroscience
26. Terpenes as Potential Anti-Alzheimer’s Disease Agents
    Elisabete Lima, Jorge Medeiros · 2024 · Applied Sciences
27. Gramine Derivatives Targeting Ca2+ Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases
    Rocío Lajarín-Cuesta, Carmen Nanclares, Juan-Alberto Arranz-Tagarro, Laura González‐Lafuente, Raquel L. Arribas, Monique Araújo de Brito, Luis Gandı́a, Cristóbal de los Rı́os · 2016 · Journal of Medicinal Chemistry
28. Risk of neurodegenerative disease due to tau phosphorylation changes and arsenic exposure via drinking water
    Davoud Pakzad, Vajihe Akbari, Mohammad Reza Sepand, Mehdi Aliomrani · 2021 · Toxicology Research
29. Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury
    Wen Hui Hu, Yunn Chyn Tung, Yanchong Zhang, Fei Liu, Khalid Iqbal · 2018 · Journal of Alzheimer s Disease
30. Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer’s disease and related tauopathies
    Jingfen Su, Yue Xiao, Linyu Wei, Huiyang Lei, Fei Sun, Weixia Wang, Jun Yin, Rui Xiong, Shihong Li, Pei Zhang et al. · 2024 · 中国科学通报：英文版
31. Accurate Spatial Heterogeneity Dissection and Gene Regulation Interpretation for Spatial Transcriptomics using Dual Graph Contrastive Learning
    Zhuohan Yu, Yuning Yang, Xingjian Chen, Ka‐Chun Wong, Zhaolei Zhang, Yuming Zhao, Xiangtao Li · 2024 · Advanced Science
32. Sex differences in the neuropathological hallmarks of Alzheimer’s disease: focus on cognitively intact elderly individuals
    Yuting Hu, Jackson Tyler Boonstra, Hugo McGurran, Jochem Stormmesand, Arja A. Sluiter, Rawien A. Balesar, Ronald W. H. Verwer, Dick Frans Swaab, Ai‐Min Bao · 2021 · Neuropathology and Applied Neurobiology
33. Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in Alzheimer's disease, cerebral ischemia and multiple sclerosis (Review)
    Johanna Andrea Gutiérrez Vargas, John Fredy Castro-Álvarez, José Fernando Zapata Berruecos, Komal Abdul‐Rahim, Anibal Arteaga‐Noriega · 2022 · Biomedical Reports
34. DHCR24 Knockdown Induces Tau Hyperphosphorylation at Thr181, Ser199, Ser262, and Ser396 Sites via Activation of the Lipid Raft-Dependent Ras/MEK/ERK Signaling Pathway in C8D1A Astrocytes
    Meiting Mai, Xiaorou Guo, Yue Ming Huang, Wenbin Zhang, Yixuan Xu, Ying Zhang, Xiaojing Bai, Junfeng Wu, Hengbing Zu · 2022 · Molecular Neurobiology
35. Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs
    Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs · 2013 · Journal of Alzheimer s Disease
36. Subtype and regional regulation of prion biomarkers in sporadic C reutzfeldt– J akob disease
    Franc Llorens, Saima Zafar, Belén Ansoleaga, Mohsin Shafiq, Rosi Blanco, Marga Carmona, Oriol Grau‐Rivera, Carlos Nos, Ellen Gelpí, José Antonio del Rı́o et al. · 2014 · Neuropathology and Applied Neurobiology
37. Therapeutic Potential of the Hsp90/Cdc37 Interaction in Neurodegenerative Diseases
    Liam Gracia, Gabriella Lora, Laura J. Blair, Umesh K. Jinwal · 2019 · Frontiers in Neuroscience
38. Brain microRNAs dysregulation: Implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer’s disease and related tauopathies
    Maryam Bazrgar, Pariya Khodabakhsh, Fatemeh Mohagheghi, Mercedes Prudencio, Abolhassan Ahmadiani · 2020 · Pharmacological Research
39. Deciphering inhibitory activity of flavonoids against tau protein kinases: a coupled molecular docking and quantum chemical study
    Hassan Rasouli, Seyed Mohammad Bagher Hosseini Ghazvini, Reza Yarani, Ali Altıntaş, Saber Ghafari Nikoo Jooneghani, Teodorico C. Ramalho · 2020 · Journal of Biomolecular Structure and Dynamics
40. Phosphorylated full‐length Tau interacts with 14‐3‐3 proteins via two short phosphorylated sequences, each occupying a binding groove of 14‐3‐3 dimer
    João Filipe Neves, Olívia Petrvalská, Francesco Bosica, François‐Xavier Cantrelle, Hamida Merzougui, Gavin O’Mahony, Xavier Hanoulle, Tomáš Obšil, Isabelle Landrieu · 2020 · FEBS Journal
41. Protective effects of a small molecule inhibitor ligand against hyperphosphorylated tau-induced mitochondrial and synaptic toxicities in Alzheimer disease
    Jangampalli Adi Pradeepkiran, Manne Munikumar, Arubala P. Reddy, P. Hemachandra Reddy · 2021 · Human Molecular Genetics
42. Interactions between GSK3β and amyloid genes explain variance in amyloid burden
    Timothy J. Hohman, Mary Ellen I. Koran, Tricia A. Thornton‐Wells · 2013 · Neurobiology of Aging
43. Molecular mechanisms of neurofilament alterations and its application in assessing neurodegenerative disorders
    Srikripa Devarakonda, Shaik Basha, Anjana Pithakumar, L B Thoshna, Darshan Chikkanayakanahalli Mukunda, Jackson Rodrigues, K Ameera, Shimul Biswas, Aparna Ramakrishna Pai, Sushma Belurkar et al. · 2024 · Ageing Research Reviews
44. REMOVED: Novel Treatment Strategies Using TiO2-Nanowired Delivery of Histaminergic Drugs and Antibodies to Tau With Cerebrolysin for Superior Neuroprotection in the Pathophysiology of Alzheimer's Disease
    Aruna Sharma, Preeti Kumaran Menon, Ranjana Patnaik, Dafin Fior Muresanu, José Vicente Lafuente, Z. Ryan Tian, Asya Ozkızılcık, Herbert Mössler, Hari Shanker Sharma · 2017 · International review of neurobiology
45. Macromolecular Structures and Proteins Interacting with the Microtubule Associated Tau Protein
    Juan S. Jiménez · 2022 · Neuroscience
46. Exploring the phytochemistry, pharmacognostic properties, and pharmacological activities of medically important plant Momordica Charantia
    Swarupananda Mukherjee, Dipanjan Karati · 2023 · Pharmacological Research - Modern Chinese Medicine
47. Prevention of Alzheimer's disease through diet: An exploratory review
    Nusrat Zahan Bhuiyan, Md. Kamrul Hasan, Zimam Mahmud, Md. Sabbir Hossain, Atiqur Rahman · 2023 · Metabolism Open
48. Cholesterol overload induces apoptosis in SH-SY5Y human neuroblastoma cells through the up regulation of flotillin-2 in the lipid raft and the activation of BDNF/Trkb signaling
    Yen-Ning Huang, Ching-I Lin, Hsiang Liao, Chin-Yu Liu, Yue-Hua Chen, Wan‐Chun Chiu, Shyh‐Hsiang Lin · 2016 · Neuroscience
49. TYK2 regulates tau levels, phosphorylation and aggregation in a tauopathy mouse model
    Jiyoen Kim, Bakhos Tadros, Yan Hong Wei Liang, Young Doo Kim, Cristian A. Lasagna‐Reeves, Jun Young Sonn, Dah‐eun Chloe Chung, Bradley T. Hyman, David M. Holtzman, Huda Yahya Zoghbi · 2024 · Nature Neuroscience
50. GSKIP-Mediated Anchoring Increases Phosphorylation of Tau by PKA but Not by GSK3beta via cAMP/PKA/GSKIP/GSK3/Tau Axis Signaling in Cerebrospinal Fluid and iPS Cells in Alzheimer Disease
    Huey-Jiun Ko, Shean-Jaw Chiou, Yu‐Hui Wong, Yin-Hsuan Wang, Yun-Ling Lai, Chia‐Hua Chou, Chihuei Wang, Joon‐Khim Loh, Ann‐Shung Lieu, Jiin‐Tsuey Cheng et al. · 2019 · Journal of Clinical Medicine
51. Fish oil protects the blood–brain barrier integrity in a mouse model of Alzheimer’s disease
    Youna Xie, Lingli Yan, Haitao Zeng, Weineng Chen, Jiahong Lu, Jian‐Bo Wan, Huanxing Su, Xiaoli Yao · 2020 · Chinese Medicine
52. The Structure Biology of Tau and Clue for Aggregation Inhibitor Design
    Dan Wang, Xianlong Huang, Lu Yan, Luo‐Qi Zhou, Yan Chang, Jinhu Wu, Zhengding Su, Yongqi Huang · 2021 · The Protein Journal
53. ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders
    Stefania Demuro, Conall Sauvey, Shailesh Kumar Tripathi, Rita Maria Concetta Di Martino, Da Shi, Jose Antonio Ortega, Debora Russo, Beatrice Balboni, Barbara Giabbai, Paola Storici et al. · 2021 · European Journal of Medicinal Chemistry
54. Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents
    Elisabete Lima, Jorge Medeiros · 2022 · Marine Drugs
55. Microtubules as Regulators of Neural Network Shape and Function: Focus on Excitability, Plasticity and Memory
    Fernando Peña‐Ortega, Ángel Abdiel Robles-Gómez, Lorena Xolalpa Cueva · 2022 · Cells
56. Plant‐derived peptides for the improvement of Alzheimer's disease: Production, functions, and mechanisms
    Like Lin, Cong Li, Tingting Li, Jingyi Zheng, Yu Shu, Jingjing Zhang, Yehua Shen, Difeng Ren · 2023 · Food Frontiers
57. Quantitative Expression Analysis of APP Pathway and Tau Phosphorylation-Related Genes in the ICV STZ-Induced Non-Human Primate Model of Sporadic Alzheimer’s Disease
    Sang-Je Park, Young-Hyun Kim, Gyu-Hwi Nam, Se-Hee Choe, Sang‐Rae Lee, Sun‐Uk Kim, Jisu Kim, Bo‐Woong Sim, Bong‐Seok Song, Kang-Jin Jeong et al. · 2015 · International Journal of Molecular Sciences
58. ERK (MAPK) does not phosphorylate tau under physiological conditions in vivo or in vitro
    Anastasia Noël, Isabelle Poitras, Jacinthe Julien, Franck R. Petry, Françoise Morin, Jean Charron, Emmanuel Planel · 2014 · Neurobiology of Aging
59. NLRP3-mediated autophagy dysfunction links gut microbiota dysbiosis to tau pathology in chronic sleep deprivation
    Na Zhao, 东南大学医学院神经内科, 江苏 南京 210009, 中国, Chen Xiu, Qiu-Gu Chen, Xue-Ting Liu, Fan Geng, Mengmeng Zhu, Fuling Yan, Zhijun Zhang, Qingguo Ren et al. · 2024 · 动物学研究
60. Hyperphosphorylation of tau by GSK-3β in Alzheimer’s disease: The interaction of Aβ and sphingolipid mediators as a therapeutic target
    Maja Jazvinšćak Jembrek, Mirjana Babić Leko, Nela Pivac, Patrick R. Hof, Goran Šimić · 2013 · Translational Neuroscience
61. Therapeutic and diagnostic challenges for frontotemporal dementia
    Simon Dâ€TMAlton, Jada M. Lewis · 2014 · Frontiers in Aging Neuroscience
62. SPR and electrochemical analyses of interactions between CYP3A4 or 3A5 and cytochrome b5
    Oksana V. Gnedenko, Evgeniy O. Yablokov, Sergey A. Usanov, Dzmitry Mukha, Г. В. Сергеев, Tatiana V. Bulko, Alexey V. Kuzikov, Natalia E. Moskaleva, Victoria V. Shumyantseva, Alexis S. Ivanov et al. · 2014 · Chemical Physics Letters
63. Subchronic exposure to acrylamide caused behaviour disorders and related pathological and molecular changes in rat cerebellum
    Ying Liu, Dandan Yan, Yiqi Wang, Xing Zhang, Na Wang, Yang Jiao, Hong Yan · 2021 · Toxicology Letters
64. Passive immunization against phosphorylated tau improves features of Huntington's disease pathology
    Alpaugh, Melanie, Masnata, Maria, de Rus Jacquet, Aurelie, Lepinay, Eva, Denis, Hélèna L., Saint-Pierre, Martine, Davies, Peter, Planel, Emmanuel, Cicchetti, Francesca · 2022 · Molecular Therapy
65. Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
    Shengnan Zhang, Yi Zhu, Jinxia Lu, Zhenying Liu, Amanda G. Lobato, Wen Zeng, Jiaqi Liu, Jiali Qiang, Shuyi Zeng, Yaoyang Zhang et al. · 2022 · eLife
66. Ser422 phosphorylation blocks human Tau cleavage by caspase-3: Biochemical implications to Alzheimer’s Disease
    Priya Sandhu, Mansur M. Naeem, Chunyu Lu, Premkumari Kumarathasan, James Gomes, Ajoy Basak · 2016 · Bioorganic & Medicinal Chemistry Letters
67. β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling
    Weiying Liu, Feng-Xian Sun, Moxin Wan, Fang Jiang, Xiangyu BO, Laixiang Lin, Hua Tang, Shumei Xu · 2018 · Frontiers in Pharmacology
68. Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy
    Tariq Ahmed, Ann Van der Jeugd, Raphaëlle Caillierez, Luc Buée, David L Blum, Rudi D’Hooge, Detlef Balschun · 2020 · Frontiers in Molecular Neuroscience
69. Inhibition of GSK_3β by Iridoid Glycosides of Snowberry (Symphoricarpos albus) Effective in the Treatment of Alzheimer’s Disease Using Computational Drug Design Methods
    Marzieh Eskandarzadeh, Parastou Kordestani-Moghadam, Saeed Pourmand, Javad Khalili Fard, Bijan Almassian, Sajjad Gharaghani · 2021 · Frontiers in Chemistry
70. Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity
    Laura Llorach-Parés, Ened Rodríguez-Urgellés, Alfons Nonell‐Canals, Jordi Alberch, Conxita Àvila, Melchor Sánchez-Martínez, Albert Giralt · 2020 · Biomolecules
71. Stoichiometric 14-3-3ζ binding promotes phospho-Tau microtubule dissociation and reduces aggregation and condensation
    Janine Hochmair, Maxime C. M. van den Oetelaar, Leandre M. Ravatt, Lisa Diez, Lenne J. M. Lemmens, Renata Ponce-Lina, Rithika Sankar, Maximilian Franck, Gesa Nolte, Ekaterina Semenova et al. · 2025 · Communications Biology
72. Inhibition of Alzheimer’s amyloid-β42 peptide aggregation by a bi-functional bis-tryptoline triazole: key insights from molecular dynamics simulations
    Simranjeet Singh Narang, Deepti Goyal, Bhupesh Goyal · 2019 · Journal of Biomolecular Structure and Dynamics
73. Anti-Inflammatory and Tau Phosphorylation–Inhibitory Effects of Eupatin
    Ching-Hsuan Chou, Kai‐Cheng Hsu, Tony Eight Lin, Chia‐Ron Yang · 2020 · Molecules
74. Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia
    Isabelle Guisle, Geoffrey Canet, Séréna Petry, Parissa Fereydouni-Forouzandeh, Françoise Morin, Rémi Kérauden, Robert A. Whittington, Frédéric Calon, Sébastien S. Hébert, Emmanuel Planel · 2022 · Neurobiology of Aging
75. Heparan Sulfate Proteoglycans in Tauopathy
    Yanan Zhu, Lauren A. Gandy, Fuming Zhang, Jian Liu, Chunyu Wang, Laura J. Blair, Robert J. Linhardt, Lianchun Wang · 2022 · Biomolecules
76. Disruption of DYRK1A-induced hyperphosphorylation of amyloid-beta and tau protein in Alzheimer’s disease: An integrative molecular modeling approach
    Rohit Shukla, Anuj Kumar, David J. Kelvin, Tiratha Raj Singh · 2023 · Frontiers in Molecular Biosciences
77. Neuroprotection and Mechanism of Gas-miR36-5p from Gastrodia elata in an Alzheimer’s Disease Model by Regulating Glycogen Synthase Kinase-3β
    Zhongteng Lu, Jianyuan Fu, Guang Wu, Zhecheng Yang, Xiaoqi Wu, Dan Wang, Zhengying You, Zuoming Nie, Qing Sheng · 2023 · International Journal of Molecular Sciences
78. Integrated analysis of differential gene expression profiles in hippocampi to identify candidate genes involved in Alzheimer's disease
    Wanhua Hu, Xiaodong Lin, KELONG CHEN · 2015 · Molecular Medicine Reports
79. Fragile X mental retardation protein: from autism to neurodegenerative disease
    Hansen Wang · 2015 · Frontiers in Cellular Neuroscience
80. GRK5 influences the phosphorylation of tau via GSK3β and contributes to Alzheimer's disease
    Jianghao Zhao, Xiaohui Li, Xiongjin Chen, Yujie Cai, Yan Wang, Wenjing Sun, Hui Mai, Jingqi Yang, Weihao Fan, Pei Tang et al. · 2018 · Journal of Cellular Physiology
81. Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms
    Aniket Kakkar, Harpreet Singh, Bhuvnesh Kumar Singh, Arvind Kumar, Arun Kumar Mishra, Hitesh Chopra · 2025 · Journal of Alzheimer s Disease
82. Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays
    Alex Crowe, Mark J. Henderson, Johnathon David Anderson, Steven A. Titus, Alexey V. Zakharov, Anton M. Simeonov, Arjan Buist, Charlotte Delay, Diederik Moechars, John Q. Trojanowski et al. · 2020 · Journal of Biological Chemistry
83. Rutaecarpine Ameliorated High Sucrose-Induced Alzheimer's Disease Like Pathological and Cognitive Impairments in Mice
    Zhao Bin, Yi Wang, Rui Liu, Xiaoli Jia, Nan Hu, Xingwei An, Chenguang Zheng, Chong Chen, Hongtao Sun, Feng Chen et al. · 2020 · Rejuvenation Research
84. Targeting Tau to Treat Clinical Features of Huntington's Disease
    Maria Masnata, Shireen Salem, Aurélie de Rus Jacquet, Mehwish Anwer, Francesca Cicchetti · 2020 · Frontiers in Neurology
85. Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau
    Mody, Prapti H., Marvin, Kelsey N., Hynds, DiAnna L., Hanson, Laura K. · 2023 · Journal of NeuroVirology
86. Tau Accumulation in the Spinal Cord Contributes to Chronic Inflammatory Pain by Upregulation of IL-1β and BDNF
    Shuxia Zhang, Yeru Chen, Yongjie Wang, Hongwei Wang, Dandan Yao, Gang Chen · 2023 · Neuroscience Bulletin
87. Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease
    Dmitry V. Eremin, Elena M. Kondaurova, Aleksander Ya Rodnyy, Camilla A. Molobekova, Dmitry Anatolievich Kudlay, Vladimir S. Naumenko · 2023 · Biochemistry (Moscow)
88. Glucose-modified BSA/procyanidin C1 NPs penetrate the blood-brain barrier and alleviate neuroinflammation in Alzheimer's disease models
    Linyan Duan, Zhizhong Hao, Rong Ji, Xingfan Li, Hao Wang, Yujing Su, Fangxia Guan, Shanshan Ma · 2024 · International Journal of Biological Macromolecules
89. Functionally specific binding regions of microtubule-associated protein 2c exhibit distinct conformations and dynamics
    Kateřina Melková, Vojtěch Zapletal, Séverine Jansen, Erik Nomilner, Milan Zachrdla, Jozef Hritz, Jiří Nováček, Markus Zweckstetter, Malene Ringkjøbing Jensen, Martin J Blackledge et al. · 2018 · Journal of Biological Chemistry
90. Streptocyclinones A and B ameliorate Alzheimer's disease pathological processes in vitro
    Rebeca Alvariño, Eva Alonso, Rodney Lacret, Daniel Oves‐Costales, Olga Genilloud, Fernando Reyes, Amparo Alfonso, Luis Miguel Botana · 2018 · Neuropharmacology
91. Chronic microglial inflammation promotes neuronal lactate supply but impairs its utilization in primary rat astrocyte-neuron co-cultures
    Yi Wang, Jie Li, Meng-Yue Wang, Zhi-Yong Pan, Zhiqiang Li, Ze-Fen Wang · 2022 · Biochemical and Biophysical Research Communications
92. Patient-Derived Fibroblasts With Presenilin-1 Mutations, That Model Aspects of Alzheimer’s Disease Pathology, Constitute a Potential Object for Early Diagnosis
    Gustavo López-Toledo, Maria‐del‐Carmen Silva‐Lucero, Jorge Herrera‐Díaz, David-Erasmo García, José‐Antonio Arias‐Montaño, María del Carmen Cárdenas‐Aguayo · 2022 · Frontiers in Aging Neuroscience
93. Long‐Term High‐Fat Diet Consumption Aggravates β‐Amyloid Deposition and Tau Pathology Accompanied by Microglial Activation in an Alzheimer's Disease Model
    Zheng Liang, Xiaokang Gong, Yang Zhao, Yanna Zhao, Jing Yu, Tiantian Huang, Chaoqing Yang, Liangwei Wu, Mengbing Huang, Xiaochuan Wang et al. · 2024 · Molecular Nutrition & Food Research
94. Development of tau phosphorylation-targeting therapies for the treatment of neurodegenerative diseases
    Jingfen Su, Yue Xiao, Xiaochuan Wang, Jie Zheng, Jian‐Zhi Wang · 2024 · Medicine Plus
95. Tibolone modulates neuronal plasticity through regulating Tau, GSK3β/Akt/PI3K pathway and CDK5 p35/p25 complexes in the hippocampus of aged male mice
    Christian Guerra‐Araiza, Teresa Neri-Gómez, Judith Espinosa‐Raya, Sofía Y. Díaz-Cintra, Julia J. Segura-Uribe, Sandra Adela Orozco-Suárez, Juan Manuel Gallardo · 2017 · Neural Regeneration Research
96. Emerging roles of protein kinases in microglia-mediated neuroinflammation
    Sun Hwa Lee, Kyoungho Suk · 2017 · Biochemical Pharmacology
97. Phlorizin administration ameliorates cognitive deficits by reducing oxidative stress, tau hyper‐phosphorylation, and neuroinflammation in a rat model of Alzheimer’s disease
    Yuan Tian, Weibing Lu, Haohua Deng, Fan Yang, Yan Guo, Ling Gao, Yancheng Xu · 2018 · Journal of Food Biochemistry
98. Early detection and personalized medicine: Future strategies against Alzheimer's disease
    Antonio Di Meco, Robert J. Vassar · 2020 · Progress in molecular biology and translational science
99. Astrocyte transport of glutamate and neuronal activity reciprocally modulate tau pathology in Drosophila
    Jason Kilian, Heng-Wei Hsu, Kenneth Mata, Fred W. Wolf, Masashi Kitazawa · 2017 · Neuroscience
100. Forskolin Induces Hyperphosphorylation of Tau Accompanied by Cell Cycle Reactivation in Primary Hippocampal Neurons
     Wang, Hai-Hong, Li, Yan, Li, Ang, Yan, Fang, Li, Zhen-Lin, Liu, Zhong-Ying, Zhang, Lei, Zhang, Jian, Dong, Wei-Ren, Zhang, Lin · 2018 · Molecular Neurobiology